Cite
CXCR4 expression of multiple myeloma as a dynamic process: influence of therapeutic agents.
MLA
Bögelein, Anna, et al. “CXCR4 Expression of Multiple Myeloma as a Dynamic Process: Influence of Therapeutic Agents.” Leukemia & Lymphoma, vol. 63, no. 10, Oct. 2022, pp. 2393–402. EBSCOhost, https://doi.org/10.1080/10428194.2022.2074986.
APA
Bögelein, A., Stolzenburg, A., Eiring, P., Lückerath, K., Munawar, U., Werner, R., Schirbel, A., Samnick, S., Kortüm, K. M., Sauer, M., Lapa, C., & Buck, A. K. (2022). CXCR4 expression of multiple myeloma as a dynamic process: influence of therapeutic agents. Leukemia & Lymphoma, 63(10), 2393–2402. https://doi.org/10.1080/10428194.2022.2074986
Chicago
Bögelein, Anna, Antje Stolzenburg, Patrick Eiring, Katharina Lückerath, Umair Munawar, Rudolf Werner, Andreas Schirbel, et al. 2022. “CXCR4 Expression of Multiple Myeloma as a Dynamic Process: Influence of Therapeutic Agents.” Leukemia & Lymphoma 63 (10): 2393–2402. doi:10.1080/10428194.2022.2074986.